Alessandra Sottini Selected Research

Alessandra Sottini Research Topics

Disease

9	Multiple Sclerosis 10/2020 - 09/2007
7	COVID-19 01/2022 - 09/2020
3	Infections 10/2020 - 05/2012
3	Pneumonia (Pneumonitis) 10/2020 - 09/2020
3	HIV Infections (HIV Infection) 01/2014 - 03/2008
2	Progressive Multifocal Leukoencephalopathy 01/2019 - 12/2014
2	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2018 - 01/2017
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2014 - 04/2013
2	Neoplasms (Cancer) 09/2010 - 03/2009
2	Melanoma (Melanoma, Malignant) 09/2010 - 03/2009
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Inflammation (Inflammations) 01/2021
1	Virus Diseases (Viral Diseases) 09/2020
1	Relapsing-Remitting Multiple Sclerosis 01/2020
1	Seizures (Absence Seizure) 01/2019
1	Immune Reconstitution Inflammatory Syndrome 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2016
1	Lymphoma (Lymphomas) 12/2016
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2015
1	Lymphopenia (Lymphocytopenia) 04/2013
1	Severe combined immunodeficiency due to adenosine deaminase deficiency 12/2010
1	Hepatitis A (Hepatitis, Infectious) 10/2002
1	Liver Diseases (Liver Disease) 10/2002

Drug/Important Bio-Agent (IBA)

6	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2020 - 03/2009
4	Peptides (Polypeptides)IBA 09/2020 - 03/2009
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2014
3	Proteins (Proteins, Gene)FDA Link 11/2021 - 09/2020
3	AntibodiesIBA 09/2020 - 09/2007
3	AntigensIBA 09/2020 - 03/2009
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 10/2002
3	Natalizumab (Tysabri)FDA Link 12/2014 - 01/2012
2	Interferon Type IIBA 10/2020 - 03/2008
2	InterferonsIBA 10/2020 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2018 - 01/2015
2	CytokinesIBA 02/2018 - 01/2015
2	Interferon-betaIBA 01/2015 - 06/2008
2	MART-1 AntigenIBA 09/2010 - 03/2009
2	VaccinesIBA 09/2010 - 03/2009
2	Messenger RNA (mRNA)IBA 06/2008 - 03/2008
1	HLA-A Antigens (HLA-A)IBA 01/2022
1	InterleukinsIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Toll-Like Receptor 3IBA 10/2020
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 10/2020
1	AutoantibodiesIBA 10/2020
1	Immunoglobulin G (IgG)IBA 10/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2020
1	Therapeutic UsesIBA 01/2020
1	Alemtuzumab (Campath)FDA Link 01/2019
1	thymoglobulin FDA Link 11/2018
1	Lenalidomide (CC 5013)FDA Link 01/2015
1	Complement System Proteins (Complement)IBA 01/2015
1	Interleukin-6 (Interleukin 6)IBA 01/2015
1	Interferon beta-1a FDA Link 01/2015
1	AntipyreticsIBA 01/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2014
1	Phenylalanine (L-Phenylalanine)FDA Link 04/2013
1	Monoclonal AntibodiesIBA 10/2012
1	IntegrinsIBA 01/2012
1	pegademase bovine (pegADA)FDA Link 12/2010
1	Dacarbazine (DIC)FDA LinkGeneric 09/2010
1	alpha-beta T-Cell Antigen Receptors (T-Cell Receptor alpha-Chain)IBA 03/2009
1	EpitopesIBA 03/2009
1	Melanoma-Specific AntigensIBA 03/2009
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2009
1	Cancer VaccinesIBA 03/2009
1	Interferon-alpha (Interferon Alfa)IBA 09/2008
1	EnzymesIBA 10/2002

Therapy/Procedure

12	Therapeutics 10/2020 - 06/2008
3	Stem Cell Transplantation 11/2018 - 12/2016
2	Hematopoietic Stem Cell Transplantation 01/2014 - 12/2010
1	Phototherapy (Light Therapy) 02/2018
1	Drug Therapy (Chemotherapy) 12/2016
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2016
1	Erythrocyte Transfusion 01/2015
1	Enzyme Replacement Therapy 12/2010